Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report
-
* Corresponding author: Martin F Sprinzl sprinzl@1-med.klinik.uni-mainz.de
- Equal contributors
BMC Cancer 2006, 6:190 doi:10.1186/1471-2407-6-190
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 30 Jan 2006 | |
| Reviewer's Report | Florian Eckel | 26 Feb 2006 | |
| Reviewer's Report | Vittorio Gebbia | 01 Mar 2006 | |
| Reviewer's Report | Tushar Patel | 08 Mar 2006 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 05 Apr 2006 |
| Resubmission - Version 3 | Manuscript | Author's comment | 03 May 2006 |
| Resubmission - Version 4 | Manuscript | Author's comment | 03 May 2006 |
| Reviewer's Report | Tushar Patel | 12 Jun 2006 | |
| Editorial acceptance | 15 Jun 2006 | ||
| Published | 17 Jul 2006 |